As of 11/20/2024
Indus: 43,408 +139.53 +0.3%
Trans: 17,002 -26.31 -0.2%
Utils: 1,055 +1.25 +0.1%
Nasdaq: 18,966 -21.33 -0.1%
S&P 500: 5,917 +0.13 +0.0%
|
YTD
+15.2%
+6.9%
+19.7%
+26.3%
+24.1%
|
46,000 or 43,000 by 12/01/2024
18,000 or 16,600 by 12/01/2024
1,075 or 1,000 by 12/01/2024
20,000 or 18,400 by 12/01/2024
6,100 or 5,800 by 12/01/2024
|
As of 11/20/2024
Indus: 43,408 +139.53 +0.3%
Trans: 17,002 -26.31 -0.2%
Utils: 1,055 +1.25 +0.1%
Nasdaq: 18,966 -21.33 -0.1%
S&P 500: 5,917 +0.13 +0.0%
|
YTD
+15.2%
+6.9%
+19.7%
+26.3%
+24.1%
| |
46,000 or 43,000 by 12/01/2024
18,000 or 16,600 by 12/01/2024
1,075 or 1,000 by 12/01/2024
20,000 or 18,400 by 12/01/2024
6,100 or 5,800 by 12/01/2024
| ||
This is an alphabetical listing of event patterns that shows the performance rank of each event pattern by its failure rate. Ties are allowed. A rank of 1 means the event pattern has the smallest failure rate. N/A in the list below means the event pattern uses a different method to gauge performance than the other event patterns (usually the measure from the breakout to the swing high or swing low, not to the highest high or lowest low before a trend change). Thus, a performance comparison would be unfair and meaningless. For more information see the book Encyclopedia of Chart Patterns, Second Edition.
-- Thomas Bulkowski
Event Pattern | Breakeven Failure Rate Rank |
Dead-Cat Bounce | N/A |
Dead-Cat Bounce, Inverted | N/A |
Flag, Earnings, up breakout | 1 |
Same Store Sales, Bad, down breakout | 1 |
Stock Downgrade, down breakout | 1 |
Earnings Surprise, Bad, down breakout | 2 |
Stock Upgrade, up breakout | 2 |
Same Store Sales, Good, up breakout | 3 |
Stock Upgrade, down breakout | 3 |
FDA Drug Approvals, down breakout | 4 |
Stock Downgrade, up breakout | 4 |
Earnings Surprise, Good, up breakout | 5 |
FDA Drug Approvals, up breakout | 6 |
Support this site! Clicking any of the books (below) takes you to
Amazon.com If you buy ANYTHING while there, they pay for the referral.
Legal notice for paid links: "As an Amazon Associate I earn from qualifying purchases."
My Stock Market Books
|
My Novels
|
A truly wise man never plays leapfrog with a unicorn.